Oltmans Curtis Gale

General Counsel at ARRAY BIOPHARMA INC · on record since Aug 17, 2017
Director at AVENUE THERAPEUTICS, INC. · on record since Dec 21, 2021
Chief Legal Officer at Fulcrum Therapeutics, Inc. · on record since Dec 7, 2020

Insider trading activity of Oltmans Curtis Gale

Transactions on record: 36; since Dec 19, 2017

Open-market buys: 1; $9.8K

Open-market sells: 5; $1.5M

Companies traded: 3; last filing Feb 4, 2026

Figures computed from official regulatory filings — .

Companies where Oltmans Curtis Gale has traded

Fulcrum Therapeutics, Inc.11 tx · $54.4K · Feb 4, 2026
AVENUE THERAPEUTICS, INC.3 tx · Sep 25, 2024
ARRAY BIOPHARMA INC22 tx · $2.3M · Feb 7, 2019

Track record of Oltmans Curtis Gale

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Oltmans Curtis Gale

Co-insiders of Oltmans Curtis Gale

6 Dimensions Capital, L.P.Fulcrum Therapeutics, Inc.
Arroyo SantiagoFulcrum Therapeutics, Inc.
Banks SonjaFulcrum Therapeutics, Inc.
BAUM CHARLES MARRAY BIOPHARMA INC
BIOTECHNOLOGY VALUE FUND II LPARRAY BIOPHARMA INC
BIOTECHNOLOGY VALUE FUND L PARRAY BIOPHARMA INC
BROOKFIELD ASSET MANAGEMENT INC.ARRAY BIOPHARMA INC
BULLOCK FRANCIS JARRAY BIOPHARMA INC
BVF INC/ILARRAY BIOPHARMA INC
BVF INVESTMENTS LLCARRAY BIOPHARMA INC
BVF PARTNERS L P/ILARRAY BIOPHARMA INC
Cadavid DiegoFulcrum Therapeutics, Inc.
CARRUTHERS MICHAELARRAY BIOPHARMA INC
CARUTHERS MARVIN HARRAY BIOPHARMA INC
Casdin Capital, LLCFulcrum Therapeutics, Inc.
Casdin EliFulcrum Therapeutics, Inc.
Casdin Partners GP, LLCFulcrum Therapeutics, Inc.
Casdin Partners Master Fund, L.P.Fulcrum Therapeutics, Inc.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Fulcrum Therapeutics, Inc.Listing on record	Feb 4, 2026	AwardD (derivative)	170,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Fulcrum Therapeutics, Inc.Listing on record	Dec 17, 2025	Sell	-3,452	12.92 USD	$44.6K		SEC
Fulcrum Therapeutics, Inc.Listing on record	Jan 28, 2025	AwardD (derivative)	225,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
AVENUE THERAPEUTICS, INC.Listing on record	Sep 25, 2024	AwardD (derivative)	30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Fulcrum Therapeutics, Inc.Listing on record	Jan 30, 2024	AwardD (derivative)	150,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
AVENUE THERAPEUTICS, INC.Listing on record	Jul 5, 2023	AwardD (derivative)	100,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Fulcrum Therapeutics, Inc.Listing on record	Apr 28, 2023	AwardD (derivative)	127,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Fulcrum Therapeutics, Inc.Listing on record	Feb 13, 2023	AwardD (derivative)	150,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Fulcrum Therapeutics, Inc.Listing on record	Aug 11, 2022	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Fulcrum Therapeutics, Inc.Listing on record	Jan 21, 2022	AwardD (derivative)	60,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Fulcrum Therapeutics, Inc.Listing on record	Jan 7, 2022	Gift	-1,088	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
AVENUE THERAPEUTICS, INC.Listing on record	Dec 21, 2021	Award	49,020	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Fulcrum Therapeutics, Inc.Listing on record	Jun 29, 2021	Buy	1,088	9.01 USD	$9.8K	conv 91ClusterFirst in 12mo	SEC
Fulcrum Therapeutics, Inc.Listing on record	Dec 7, 2020	AwardD (derivative)	153,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ARRAY BIOPHARMA INCListing unverified	Feb 7, 2019	Exercise	40,000	8.94 USD	$357.6K	Unusual size	SEC
ARRAY BIOPHARMA INCListing unverified	Feb 7, 2019	Exercise	11,100	8.94 USD	$99.2K		SEC
ARRAY BIOPHARMA INCListing unverified	Feb 7, 2019	Sell	-40,000	20.00 USD	$800K	Unusual size	SEC
ARRAY BIOPHARMA INCListing unverified	Feb 7, 2019	ExerciseD (derivative)	-40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ARRAY BIOPHARMA INCListing unverified	Jan 29, 2019	Sell	-14,029	18.00 USD	$252.5K		SEC
ARRAY BIOPHARMA INCListing unverified	Jan 29, 2019	ExerciseD (derivative)	-14,029	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ARRAY BIOPHARMA INCListing unverified	Jan 29, 2019	Exercise	14,029	8.94 USD	$125.4K		SEC
ARRAY BIOPHARMA INCListing unverified	Jan 29, 2019	ExerciseD (derivative)	-11,100	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ARRAY BIOPHARMA INCListing unverified	Jan 23, 2019	ExerciseD (derivative)	-1,251	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ARRAY BIOPHARMA INCListing unverified	Jan 23, 2019	Exercise	1,251	8.94 USD	$11.2K		SEC
ARRAY BIOPHARMA INCListing unverified	Jan 23, 2019	Sell	-1,251	18.00 USD	$22.5K		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Fulcrum Therapeutics, Inc.Listing on record	Feb 4, 2026	AwardD (derivative)	170,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Fulcrum Therapeutics, Inc.Listing on record	Dec 17, 2025	Sell	-3,452	12.92 USD	$44.6K		SEC
Fulcrum Therapeutics, Inc.Listing on record	Jan 28, 2025	AwardD (derivative)	225,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
AVENUE THERAPEUTICS, INC.Listing on record	Sep 25, 2024	AwardD (derivative)	30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Fulcrum Therapeutics, Inc.Listing on record	Jan 30, 2024	AwardD (derivative)	150,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
AVENUE THERAPEUTICS, INC.Listing on record	Jul 5, 2023	AwardD (derivative)	100,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Fulcrum Therapeutics, Inc.Listing on record	Apr 28, 2023	AwardD (derivative)	127,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Fulcrum Therapeutics, Inc.Listing on record	Feb 13, 2023	AwardD (derivative)	150,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Fulcrum Therapeutics, Inc.Listing on record	Aug 11, 2022	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Fulcrum Therapeutics, Inc.Listing on record	Jan 21, 2022	AwardD (derivative)	60,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Fulcrum Therapeutics, Inc.Listing on record	Jan 7, 2022	Gift	-1,088	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
AVENUE THERAPEUTICS, INC.Listing on record	Dec 21, 2021	Award	49,020	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Fulcrum Therapeutics, Inc.Listing on record	Jun 29, 2021	Buy	1,088	9.01 USD	$9.8K	conv 91ClusterFirst in 12mo	SEC
Fulcrum Therapeutics, Inc.Listing on record	Dec 7, 2020	AwardD (derivative)	153,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ARRAY BIOPHARMA INCListing unverified	Feb 7, 2019	Exercise	40,000	8.94 USD	$357.6K	Unusual size	SEC
ARRAY BIOPHARMA INCListing unverified	Feb 7, 2019	Exercise	11,100	8.94 USD	$99.2K		SEC
ARRAY BIOPHARMA INCListing unverified	Feb 7, 2019	Sell	-40,000	20.00 USD	$800K	Unusual size	SEC
ARRAY BIOPHARMA INCListing unverified	Feb 7, 2019	ExerciseD (derivative)	-40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ARRAY BIOPHARMA INCListing unverified	Jan 29, 2019	Sell	-14,029	18.00 USD	$252.5K		SEC
ARRAY BIOPHARMA INCListing unverified	Jan 29, 2019	ExerciseD (derivative)	-14,029	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ARRAY BIOPHARMA INCListing unverified	Jan 29, 2019	Exercise	14,029	8.94 USD	$125.4K		SEC
ARRAY BIOPHARMA INCListing unverified	Jan 29, 2019	ExerciseD (derivative)	-11,100	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ARRAY BIOPHARMA INCListing unverified	Jan 23, 2019	ExerciseD (derivative)	-1,251	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ARRAY BIOPHARMA INCListing unverified	Jan 23, 2019	Exercise	1,251	8.94 USD	$11.2K		SEC
ARRAY BIOPHARMA INCListing unverified	Jan 23, 2019	Sell	-1,251	18.00 USD	$22.5K		SEC